Can the death of a child be good?

Susan Bush Welch1

  • 1School of Nursing, Marshall University, Huntington, WV 25755, USA. welchs@marshall.edu

Insights

Annually, 54,000 children die, highlighting the need for better pediatric palliative and end-of-life care. Analyzing the concept of a "good death" can guide nurses in providing evidence-based, developmentally appropriate care for dying children and their families.

Area of Science:

  • Pediatric Nursing
  • Palliative Care
  • End-of-Life Care

Background:

  • Despite medical advances, 54,000 children die annually from acute and chronic illnesses.
  • There is a growing demand for enhanced palliative and end-of-life care services for pediatric patients.
  • The concept of a "good death," widely discussed in adult hospice care, requires specific consideration in pediatrics.

Purpose of the Study:

  • To analyze the concept of a "good death" within the context of pediatric care.
  • To provide a framework for pediatric nurses to understand and implement end-of-life care.
  • To facilitate collaboration between clinical and research nursing to develop evidence-based care.

Main Methods:

  • Conceptual analysis of "good death" in pediatric end-of-life care.
  • Literature review on adult hospice and pediatric palliative care concepts.
  • Framework development for nursing practice and research.

Main Results:

  • The concept of a "good death" for children needs adaptation from adult models.
  • A framework is proposed to guide nurses in understanding and applying "good death" principles.
  • Emphasis on evidence-based, developmentally appropriate care is crucial.

Conclusions:

  • Understanding "good death" is essential for pediatric nurses caring for dying children.
  • A collaborative approach between clinical practice and research can improve pediatric end-of-life care.
  • Further development and implementation of this framework are recommended to enhance care quality.

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Bonanno's Theory of Grieving01:17

Bonanno's Theory of Grieving

Grieving is a complex psychological and emotional process that varies significantly among individuals. George Bonanno's research on bereavement identified four distinct patterns of grieving, offering a nuanced understanding of how people cope with significant loss, such as the death of a spouse, over extended periods. These patterns — resilience, recovery, chronic dysfunction, and delayed grief — highlight the diversity in emotional responses and adaptive mechanisms.
Resilience
The resilience...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Kubler Ross's Stages of Dying01:21

Kubler Ross's Stages of Dying

Elisabeth Kübler-Ross significantly advanced psychology's understanding of the process of dying with her influential book, On Death and Dying (1969). She focused on studying terminally ill individuals and outlined five stages commonly experienced when coping with death: denial, anger, bargaining, depression, and acceptance.
In denial, individuals reject the reality of their condition, often thinking, "This isn't true; I feel fine," as a way to protect themselves from emotional distress. Anger...